Stock listing
KRX:039200 Oscotec Inc. (오스코텍) 주가
Follow Oscotec Inc. into a list and get an email when it puts out news.
Share price · KRX:039200
₩31,650 KRW -650 (-2.0%)
Close on Nov 20, 2026
- Day range
- ₩31,400 – ₩32,500 KRWNov 20, 2026
- Volume
- 71,620 sharesNov 20, 2026
- Market cap
- ₩889.4B KRWAt the close on Nov 20, 2026 · price × 28.10M shares outstanding
- 52-week range
- ₩27,300 – ₩66,000 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩4.43B KRWMedian day 111,103 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:039200 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩31,650 | -650 | -2.0% | ₩32,000 | ₩32,500 | ₩31,400 | 71,620 | |
| ₩32,300 | -450 | -1.4% | ₩32,950 | ₩34,000 | ₩32,050 | 119,739 | |
| ₩32,750 | -1,500 | -4.4% | ₩34,100 | ₩34,750 | ₩32,700 | 139,342 | |
| ₩34,250 | -1,550 | -4.3% | ₩36,500 | ₩36,700 | ₩34,250 | 92,548 | |
| ₩35,800 | +100 | +0.3% | ₩36,200 | ₩38,300 | ₩35,750 | 152,332 | |
| ₩35,700 | -1,800 | -4.8% | ₩37,150 | ₩38,150 | ₩35,500 | 92,055 | |
| ₩37,500 | +1,450 | +4.0% | ₩36,000 | ₩38,100 | ₩35,900 | 93,980 | |
| ₩36,050 | -100 | -0.3% | ₩37,100 | ₩37,950 | ₩35,700 | 107,156 | |
| ₩36,150 | -150 | -0.4% | ₩36,000 | ₩37,850 | ₩35,450 | 121,079 | |
| ₩36,300 | -1,200 | -3.2% | ₩36,150 | ₩39,450 | ₩34,000 | 230,658 | |
| ₩37,500 | +650 | +1.8% | ₩37,750 | ₩39,250 | ₩37,100 | 231,784 | |
| ₩36,850 | +1,450 | +4.1% | ₩35,450 | ₩36,900 | ₩34,250 | 149,548 | |
| ₩35,400 | 0 | 0.0% | ₩34,450 | ₩35,500 | ₩34,100 | 101,397 | |
| ₩35,400 | -1,050 | -2.9% | ₩36,450 | ₩36,450 | ₩35,250 | 71,764 | |
| ₩36,450 | -50 | -0.1% | ₩36,350 | ₩36,800 | ₩35,300 | 122,955 | |
| ₩36,500 | -150 | -0.4% | ₩37,200 | ₩37,200 | ₩35,850 | 95,414 | |
| ₩36,650 | +750 | +2.1% | ₩36,000 | ₩37,400 | ₩36,000 | 82,427 | |
| ₩35,900 | -100 | -0.3% | ₩36,350 | ₩37,450 | ₩35,700 | 122,139 | |
| ₩36,000 | -1,250 | -3.4% | ₩36,750 | ₩37,250 | ₩36,000 | 60,537 | |
| ₩37,250 | -250 | -0.7% | ₩37,350 | ₩38,000 | ₩36,650 | 93,792 | |
| ₩37,500 | -300 | -0.8% | ₩37,550 | ₩38,500 | ₩36,850 | 103,609 | |
| ₩37,800 | +300 | +0.8% | ₩38,250 | ₩39,500 | ₩37,600 | 122,487 | |
| ₩37,500 | -800 | -2.1% | ₩37,700 | ₩39,350 | ₩36,900 | 276,842 | |
| ₩38,300 | +1,600 | +4.4% | ₩36,700 | ₩38,550 | ₩36,150 | 195,116 | |
| ₩36,700 | +1,950 | +5.6% | ₩34,650 | ₩38,250 | ₩34,650 | 207,123 | |
| ₩34,750 | -1,050 | -2.9% | ₩35,000 | ₩35,400 | ₩34,150 | 97,900 | |
| ₩35,800 | +450 | +1.3% | ₩35,000 | ₩36,550 | ₩34,950 | 98,066 | |
| ₩35,350 | -1,150 | -3.2% | ₩36,400 | ₩36,400 | ₩34,600 | 110,874 | |
| ₩36,500 | -1,200 | -3.2% | ₩37,600 | ₩37,850 | ₩36,300 | 77,284 | |
| ₩37,700 | -2,000 | -5.0% | ₩39,500 | ₩39,950 | ₩37,400 | 120,779 | |
| ₩39,700 | +550 | +1.4% | ₩39,200 | ₩40,850 | ₩39,200 | 149,742 | |
| ₩39,150 | +2,550 | +7.0% | ₩36,600 | ₩39,250 | ₩36,450 | 180,041 | |
| ₩36,600 | -1,400 | -3.7% | ₩38,350 | ₩38,550 | ₩36,150 | 114,016 | |
| ₩38,000 | +2,350 | +6.6% | ₩35,400 | ₩38,000 | ₩35,150 | 180,025 | |
| ₩35,650 | 0 | 0.0% | ₩35,900 | ₩36,150 | ₩35,300 | 73,453 | |
| ₩35,650 | +400 | +1.1% | ₩35,150 | ₩35,800 | ₩34,300 | 111,332 | |
| ₩35,250 | -550 | -1.5% | ₩36,200 | ₩36,800 | ₩35,050 | 84,506 | |
| ₩35,800 | -400 | -1.1% | ₩36,100 | ₩36,700 | ₩35,300 | 74,922 | |
| ₩36,200 | +350 | +1.0% | ₩36,200 | ₩37,000 | ₩35,950 | 68,511 | |
| ₩35,850 | -700 | -1.9% | ₩36,700 | ₩37,700 | ₩35,700 | 80,459 | |
| ₩36,550 | -900 | -2.4% | ₩37,600 | ₩37,600 | ₩36,300 | 127,091 | |
| ₩37,450 | +3,100 | +9.0% | ₩34,700 | ₩37,600 | ₩34,700 | 223,870 | |
| ₩34,350 | -250 | -0.7% | ₩34,350 | ₩34,650 | ₩33,950 | 44,157 | |
| ₩34,600 | 0 | 0.0% | ₩34,850 | ₩35,600 | ₩34,500 | 85,918 | |
| ₩34,600 | -300 | -0.9% | ₩33,500 | ₩35,000 | ₩33,450 | 65,258 | |
| ₩34,900 | -550 | -1.6% | ₩34,300 | ₩35,200 | ₩34,300 | 74,822 | |
| ₩35,450 | +650 | +1.9% | ₩34,100 | ₩35,450 | ₩33,650 | 114,415 | |
| ₩34,800 | -250 | -0.7% | ₩34,650 | ₩35,600 | ₩34,600 | 88,800 | |
| ₩35,050 | -900 | -2.5% | ₩35,800 | ₩36,100 | ₩35,050 | 84,729 | |
| ₩35,950 | -650 | -1.8% | ₩36,600 | ₩37,050 | ₩35,750 | 108,920 | |
| ₩36,600 | +700 | +1.9% | ₩36,100 | ₩37,000 | ₩35,400 | 152,390 | |
| ₩35,900 | -700 | -1.9% | ₩36,950 | ₩37,100 | ₩35,600 | 76,905 | |
| ₩36,600 | -400 | -1.1% | ₩36,200 | ₩37,550 | ₩35,800 | 133,075 | |
| ₩37,000 | +1,950 | +5.6% | ₩35,150 | ₩37,200 | ₩35,150 | 161,788 | |
| ₩35,050 | -750 | -2.1% | ₩35,000 | ₩35,950 | ₩34,500 | 142,298 | |
| ₩35,800 | +750 | +2.1% | ₩34,700 | ₩35,950 | ₩34,500 | 68,039 | |
| ₩35,050 | -850 | -2.4% | ₩35,500 | ₩35,650 | ₩33,900 | 262,836 | |
| ₩35,900 | -1,400 | -3.8% | ₩37,000 | ₩38,150 | ₩35,700 | 106,760 | |
| ₩37,300 | -950 | -2.5% | ₩37,800 | ₩38,300 | ₩35,850 | 142,343 | |
| ₩38,250 | +1,550 | +4.2% | ₩36,800 | ₩38,800 | ₩36,800 | 133,762 | |
| ₩36,700 | -2,150 | -5.5% | ₩37,900 | ₩38,500 | ₩35,900 | 125,180 | |
| ₩38,850 | +750 | +2.0% | ₩39,300 | ₩40,000 | ₩37,500 | 153,061 |
Splits
3 splits since 2009 · KRX:039200 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 89-for-82 | Split | |
| 2-for-1 | Split | |
| 38-for-37 | Split |
- Ticker
- KRX:039200
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW
Oscotec Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
Valuation
P/E 11.6× against a median of 2.7×: the highest of 4 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩889.4B KRW
- P/E
- 11.6×
- EV/sales
- 6.3×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 4.5×
- Gross margin
- 98.6%
- Operating margin
- 67.9%
- Net margin
- 54.0%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Oscotec Inc. · KRX:039200 | US$660.8M | US$660.8M | 11.6× | 6.3× | n/a | 4.5× | 54.0% | 0.0× | n/a |
| Lexicon Pharmaceuticals, Inc. · NASDAQ:LXRX | US$681.2M | US$549.9M | n/a | 14.3× | n/a | 4.2× | −161.8% | 0.3× | 1.15 |
| CARsgen Therapeutics Holdings Ltd. · HKEX:2171 | US$676.1M | US$476.8M | n/a | 25.3× | n/a | 4.1× | −77.9% | 0.1× | n/a |
| Philogen SpA · MIL:PHIL | US$672.3M | US$532.7M | 2.7× | 1.5× | n/a | 1.6× | 71.8% | 0.0× | n/a |
| Nuvectis Pharma, Inc. · NASDAQ:NVCT | US$666.8M | US$526.1M | n/a | n/a | n/a | 5.3× | n/a | 0.0× | 0.84 |
| Sun Pharma Advanced Research Co. Ltd. · NSE:SPARC | US$666.0M | US$519.1M | 3.8× | 2.5× | 2.9× | 4.3× | 84.7% | 0.0× | n/a |
| Shouyao Holdings Beijing Co. Ltd. Class A · SSE:688197 | US$648.7M | US$566.3M | n/a | 37.8× | n/a | 6.8× | −18.6% | 0.0× | n/a |
| Prime Medicine, Inc. · NASDAQ:PRME | US$645.8M | US$695.1M | n/a | 98.4× | n/a | 76.5× | n/a | 13.1× | 2.28 |
| Sagimet Biosciences Inc. - Series A · NASDAQ:SGMT | US$638.7M | US$404.3M | n/a | n/a | n/a | 2.6× | n/a | 0.0× | 1.96 |
| Gubra A/S · OMXCOP:GUBRA | US$638.5M | US$533.6M | 2.6× | 1.4× | 1.7× | 4.2× | 64.1% | 0.2× | n/a |
| Kura Oncology, Inc. · NASDAQ:KURA | US$634.9M | US$152.6M | n/a | 1.9× | n/a | 35.4× | −369.3% | 0.6× | 1.30 |
| Median of the others | US$657.3M | US$529.4M | 2.7× | 8.4× | 2.3× | 4.2× | −18.6% | 0.0× | 1.30 |
Forecasts
Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.
- Price target
- 75000.00 KRW · Analysts' mean
- EPS, year to Dec 2026
- 841.00 · 1 analyst
- Revenue, year to Dec 2026
- 84B · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Sanghyun Lee | Current CEO, Oscotec Inc. |
| Taeyoung Yoon | Current CEO, Oscotec Inc. |
| Dongjun Shin | Current Executive Vice President, Oscotec Inc. |
| Jinhyung Kang | Current Executive Vice President, Oscotec Inc. |
| Youngshin Kwak | Current Vice President, Oscotec Inc. |
Board
| Director | Role |
|---|---|
| Dongjun Shin | Current Executive Vice President, Oscotec Inc. |
| Jinhyung Kang | Current Executive Vice President, Oscotec Inc. |
| Kyungsup Lee | Current Independent Director, Oscotec Inc. |
| Kyusik Kim | Current Independent Director, Oscotec Inc. |
| Sanghyun Lee | Current CEO, Oscotec Inc. |
| Taeyoung Yoon | Current CEO, Oscotec Inc. |
| Youngshin Kwak | Current Vice President, Oscotec Inc. |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 18, 2026 | −3.4% |
| Q2 2026 | Aug 19, 2026 | +6.2% |
| Q1 2026 | May 13, 2026 · Before open | −3.8% |
| Q4 2025 | Feb 25, 2026 · Before open | −1.8% |
| Q3 2025 | Nov 11, 2025 · Before open | −3.0% |
| Q2 2025 | Aug 12, 2025 · Before open | +0.8% |
| Q1 2025 | May 14, 2025 · Before open | +0.2% |
| Q4 2024 | Feb 26, 2025 · Before open | +3.3% |
| Q3 2024 | Nov 12, 2024 · After close | +0.4% |
| Q2 2024 | Aug 14, 2024 · After close | +6.7% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 14, 2024 · After close | +2.3% |
| Q4 2023 | Mar 18, 2024 · After close | +0.2% |
| Q3 2023 | Nov 14, 2023 · After close | +3.5% |
| Q2 2023 | Aug 14, 2023 · After close | 0.0% |
| Q1 2023 | May 12, 2023 · After close | +1.6% |
| Q4 2022 | Mar 17, 2023 · Before open | +2.2% |
| Q3 2022 | Nov 14, 2022 · Before open | −0.6% |
| Q2 2022 | Aug 16, 2022 · Before open | −2.7% |
| Q1 2022 | May 13, 2022 · Before open | +1.4% |
| Q4 2021 | Mar 7, 2022 | −3.2% |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 99.8B | 34.0B | 4.95B | 5.06B | 3.90B | 43.5B | 4.37B | 18.7B | 3.91B | 3.55B |
| Cost of revenue | 1.95B | 2.23B | 2.03B | 2.02B | 1.95B | 1.89B | 2.09B | 2.44B | 1.69B | 1.50B |
| Gross profit | 97.9B | 31.8B | 2.92B | 3.04B | 1.95B | 41.6B | 2.27B | 16.3B | 2.22B | 2.06B |
| Research and development | 27.6B | 21.4B | 24.9B | 23.3B | 22.7B | 32.8B | 15.4B | 6.97B | 4.82B | 6.55B |
| Selling, general and administrative | 7.46B | 11.3B | 8.98B | 6.74B | 5.97B | 6.23B | 6.13B | 2.85B | 2.93B | 1.92B |
| Operating income | 52.1B | -3.41B | -32.7B | -29.3B | -29.1B | 1.36B | -19.9B | 6.18B | -3.66B | -4.11B |
| Depreciation and amortization | 1.65B | 1.89B | 1.81B | 1.66B | 1.54B | 1.07B | 620.6M | 307.9M | 317.3M | 289.8M |
| EBITDA | 53.7B | -1.52B | -30.8B | -27.6B | -27.6B | 2.43B | -19.3B | 6.49B | -3.34B | -3.82B |
| Interest expense | 2.27B | 1.09B | 406.6M | 316.4M | 107.6M | 709.2M | 1.08B | 0 | 0 | 0 |
| Income before tax | 52.8B | -1.12B | -32.3B | -28.0B | -28.6B | 1.29B | -22.7B | 5.20B | -4.28B | -4.91B |
| Income tax | 6.93M | 3.34B | 2.31B | 921.0M | 0 | -36.8M | ||||
| Net income | 52.3B | 876.5M | -24.3B | -24.4B | -26.3B | -4.36B | -22.4B | 3.47B | -3.89B | -3.65B |
| Earnings per share, basic | 1,368.15 | 22.92 | -639.20 | -664.88 | -829.41 | -140.60 | -741.77 | 119.24 | -137.92 | -137.27 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 15.2B | 13.1B | 7.95B | 53.0K | 10.6B | 5.79B | 49.2B | 26.4B | 19.7B | 3.17B |
| Short-term investments | 92.9B | 89.6B | 89.5B | 98.2B | 4.00B | 22.3B | 3.48B | 9.30B | 4.06B | 6.56B |
| Receivables | 87.6B | 34.8B | 1.79B | 1.61B | 599.2M | 24.6B | 765.7M | 19.2B | 3.91B | 5.65B |
| Inventory | 1.82B | 1.77B | 1.70B | 1.27B | 1.20B | 1.10B | 1.02B | 1.00B | 884.6M | 827.8M |
| Current assets | 199.0B | 141.2B | 102.4B | 107.9B | 17.0B | 55.0B | 55.3B | 57.3B | 29.5B | 17.5B |
| Property, plant and equipment | 18.1B | 19.1B | 23.2B | 12.8B | 15.5B | 11.5B | 9.49B | 8.44B | ||
| Total assets | 229.9B | 170.8B | 132.6B | 143.7B | 49.0B | 76.4B | 72.4B | 70.3B | 40.5B | 40.8B |
| Accounts payable | 60.4M | 20.4M | 895.6M | 705.6M | 310.2M | 315.2M | 202.8M | 355.7M | 94.4M | 110.1M |
| Current liabilities | 39.0B | 34.8B | 34.8B | 18.6B | 14.4B | 15.5B | 14.4B | 15.7B | 11.7B | 8.91B |
| Long-term debt | 0 | 187.7M | 563.2M | 1.26B | 1.31B | 1.68B | 2.08B | 2.18B | ||
| Total debt | 1.31B | 2.42B | 3.75B | 5.09B | 5.32B | |||||
| Total liabilities | 43.0B | 38.4B | 37.9B | 21.2B | 20.1B | 23.3B | 21.1B | 24.0B | 19.3B | 14.5B |
| Shareholders' equity | 181.3B | 127.8B | 98.9B | 122.5B | 28.8B | 53.1B | 51.3B | 46.3B | 21.2B | 26.3B |
| Shares outstanding | 38.3M | 38.2M | 38.0M | 36.7M | 31.7M | 31.0M | 30.2M | 29.1M | 28.2M | 26.6M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 8.30B | -26.0B | -22.0B | -26.4B | -8.76B | -17.9B | 27.5M | -5.08B | -3.69B | -8.21B |
| Capital spending | -779.6M | -691.9M | -581.2M | -1.25B | -7.52B | -5.22B | -4.19B | -1.72B | -61.5M | -7.08B |
| Free cash flow | 7.52B | -26.7B | -22.6B | -27.7B | -19.1B | -23.1B | -4.16B | -6.80B | -3.75B | -15.3B |
| Cash from investing | -327.7M | 13.4B | -99.6B | 6.78B | -24.4B | 1.77B | -7.92B | 2.84B | 10.7B | |
| Cash from financing | 30.3B | 11.1B | 120.3B | 6.26B | -1.01B | 20.8B | 19.3B | 17.9B | -1.33B | |
| Share buybacks | 6.58B | 9.51B | 117.4B | 728.0M | 14.8K | 480.1M | 228.8M | 7.22B | -1.43B | |
| Change in cash | 2.09B | 5.15B | 2.43B | -5.06B | 4.79B | -43.4B | 22.9B | 6.66B | 16.4B | 1.18B |
Cap table
Built by 6ix from Oscotec Inc.’s releases
- Common shares
- 28,101,800
- Fully diluted
- 28,101,800
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 28,101,800 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 28,101,800 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Dongjun Shin | Current Executive Vice President, Oscotec Inc. · Since at least Nov 5, 2026 |
| Jinhyung Kang | Current Executive Vice President, Oscotec Inc. · Since at least Nov 5, 2026 |
| Kyungsup Lee | Current Independent Director, Oscotec Inc. · Since at least Nov 5, 2026 |
| Kyusik Kim | Current Independent Director, Oscotec Inc. · Since at least Nov 5, 2026 |
| Sanghyun Lee | Current CEO, Oscotec Inc. · Since at least Nov 5, 2026 |
| Taeyoung Yoon | Current CEO, Oscotec Inc. · Since at least Nov 5, 2026 |
| Youngshin Kwak | Current Vice President, Oscotec Inc. · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Oscotec Inc.